Production (Stage)
HOOKIPA Pharma Inc.
HOOK
$1.53
-$0.03-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.35M | 43.95M | 50.00M | 52.16M | 53.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.35M | 43.95M | 50.00M | 52.16M | 53.55M |
| Cost of Revenue | 40.23M | 47.54M | 55.70M | 64.76M | 64.92M |
| Gross Profit | -30.88M | -3.59M | -5.71M | -12.60M | -11.36M |
| SG&A Expenses | 24.43M | 21.60M | 20.45M | 18.63M | 19.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.25M | 88.73M | 95.75M | 102.99M | 103.45M |
| Operating Income | -74.90M | -44.79M | -45.75M | -50.83M | -49.90M |
| Income Before Tax | -73.42M | -43.61M | -43.21M | -48.43M | -47.35M |
| Income Tax Expenses | -106.00K | -106.00K | 164.00K | 164.00K | 164.00K |
| Earnings from Continuing Operations | -73.31 | -43.50 | -43.37 | -48.60 | -47.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.31M | -43.50M | -43.37M | -48.60M | -47.52M |
| EBIT | -74.90M | -44.79M | -45.75M | -50.83M | -49.90M |
| EBITDA | -72.40M | -42.03M | -42.42M | -47.71M | -46.63M |
| EPS Basic | -5.85 | -3.47 | -3.69 | -4.31 | -4.96 |
| Normalized Basic EPS | -3.38 | -1.85 | -1.47 | -1.91 | -2.32 |
| EPS Diluted | -5.85 | -3.48 | -3.69 | -4.31 | -4.97 |
| Normalized Diluted EPS | -3.38 | -1.85 | -1.47 | -1.91 | -2.32 |
| Average Basic Shares Outstanding | 50.16M | 50.21M | 48.96M | 47.46M | 43.19M |
| Average Diluted Shares Outstanding | 50.16M | 50.21M | 48.96M | 47.46M | 43.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |